In recent years, a potent neuroprotective agent, erythropoietin (EPO), has been demonstrated to enhance the permeability of astrocyte AQP4 and might directly lower the risk of astrocyte swelling in stroke and other brain disorders (Gunnarson et al., 2009). The gene discussed is AQP4; the disease is Stroke.